High Grade Gastroenteropancreatic Neuroendocrine Carcinoma
1 clinical trials · Condition
◉ Watch High Grade Gastroenteropancreatic Neuroendocrine Carcinoma
| Record | Firm | Date |
|---|---|---|
| Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors (NCT02709889) | AbbVie | 2016-09-23 |
Track High Grade Gastroenteropancreatic Neuroendocrine Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.